JREG
- JPMorgan Global Research Enhanced Index Equity (ESG) UCITS ETF USD (acc)Key Information
| Earliest date | 2016-02-03 |
| Exchange | LSE |
| Instrument Type | ETF |
| MIC Code | XLON |
| Website | https://www.poxelpharma.com |
| Country | United Kingdom |
ETF Information
| Fund Provider | JPMorgan Chase |
| Index | JP Morgan Global Research Enhanced Index Equity (ESG) |
| Expense Ratio | 0.25% |
| Number Of Holdings | 699 |
| Inception Date | 2018-10-10 |
| Asset Class | Equity |
| Other Symbols | JGRE, JREG |
| Currency | USD |
| Distribution Policy | Accumulating |
| Listing | EU-listed |
| Investment Style | Growth |
| Non-leveraged | Non-leveraged |
About JREG
The JPMorgan Global Research Enhanced Index Equity (ESG) UCITS ETF USD (acc) is an actively managed equity ETF that invests in companies from developed markets, seeking to generate a higher return than the MSCI World while avoiding companies with negative ESG impacts.